# Ciprofloxacin

NDC: 68788-8875
Generic name: Ciprofolxacin
Labeler / Manufacturer: Preferred Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250519

FDA application: ANDA208921

## Active ingredients

- CIPROFLOXACIN HYDROCHLORIDE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68788-8875"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68788-8875
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15755a35-e29a-47c1-89ab-e6645bb3ade9